CPT2 and hepatocellular carcinoma: A thorough examination of metabolic profiles in obesity-induced HCC mouse models revealed a notable accumulation of long-chain acylcarnitine species, which is attributed to reduced conversion of acylcarnitine to acyl-CoA, probably due to reduced expression of CPT2.